You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phosphate binder adherence

Showing 1 - 25 of 7,344
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Kidney Disease Requiring Chronic Dialysis, Hyperphosphatemia Trial in Lauderdale Lakes (Tenapanor)

Completed
  • Chronic Kidney Disease Requiring Chronic Dialysis
  • Hyperphosphatemia
  • Lauderdale Lakes, Florida
    South Florida Research Institute
Sep 28, 2022

Hyperphosphatemia Trial in Suita (KHK7791, Placebo)

Completed
  • Hyperphosphatemia
  • Suita, Osaka, Japan
    Inoue Hospital
Oct 26, 2021

Hyperphosphatemia Trial in Kanoya (KHK7791)

Active, not recruiting
  • Hyperphosphatemia
  • Kanoya, Kagoshima, Japan
    Medical Corporation Seijinkai Ikeda Hospital
Sep 7, 2021

Acne Trial in Winston-Salem (Adapalene Gel, Adapalene Gel and the clindamycin phosphate/benzoyl peroxide gel, adapalene, benzoyl

Not yet recruiting
  • Acne
  • Adapalene Gel
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jan 31, 2023

Maintenance Hemodialysis, Hyperphosphatemia Trial in Shanghai (Phosphate-binder intervention, Phosphorus-restricted dietary

Completed
  • Maintenance Hemodialysis
  • Hyperphosphatemia
  • Phosphate-binder intervention
  • Phosphorus-restricted dietary intervention
  • Shanghai, Shanghai, China
  • +1 more
Aug 25, 2021

Improving Phosphate Control in Children With CKD

Not yet recruiting
  • Chronic Kidney Diseases
  • +4 more
  • Knowledge questionnaire
  • Focus groups
  • (no location specified)
Jun 30, 2022

Lanthanum Carbonate in Patients Previously Treated With

Completed
Has Results
  • End Stage Renal Disease
  • Lanthanum carbonate
  • Homberg, Hesse, Germany
  • +30 more
Jun 4, 2021

Kidney Diseases Trial in Worldwide (Lanthanum carbonate)

Terminated
  • Kidney Diseases
  • Lanthanum carbonate
  • Feldkirch Tisis, Austria
  • +13 more
May 21, 2021

Chronic Kidney Diseases, Hemodialysis Complication, Hyperphosphatemia Trial in Cairo (Cholestyramine Resin 4000 MG [Questran],

Enrolling by invitation
  • Chronic Kidney Diseases
  • +2 more
  • Cholestyramine Resin 4000 MG [Questran]
  • Calcium Carbonate 500 MG Oral Tablet
  • Cairo, Egypt
    Ain Shams university
Oct 10, 2022

Hyperphosphatemia, End Stage Renal Disease on Dialysis Trial in Batu Caves, Petaling Jaya, Kuala Lumpur (Phosphate mobile app,

Completed
  • Hyperphosphatemia
  • End Stage Renal Disease on Dialysis
  • Phosphate mobile app
  • One-off dietary counselling with a phosphate booklet
  • Batu Caves, Selangor, Malaysia
  • +2 more
Mar 8, 2021

Chronic Kidney Disease Trial in Denver (SBR759)

Completed
  • Chronic Kidney Disease
  • Denver, Colorado
    Novartis Investigator Site
Dec 11, 2020

Hyperphosphatemia Trial in Chiba (KHK7791, Placebp)

Completed
  • Hyperphosphatemia
  • Chiba, Japan
    Study Site 1
Jan 14, 2020

Hyperphosphatemia Trial in Niigata (KHK7791)

Completed
  • Hyperphosphatemia
  • Niigata, Japan
    Study Site 1
Jan 14, 2020

Hyperphosphatemia Trial in United States (Tenapanor, Placebo, Phosphate Binder Agents)

Completed
  • Hyperphosphatemia
  • Huntsville, Alabama
  • +47 more
Aug 31, 2020

Peritoneal Dialysis Complication, Hyperphosphatemia, Hypoalbuminemia Trial in Aurora (Sucroferric Oxyhydroxide Chewable Tablet)

Completed
Has Results
  • Peritoneal Dialysis Complication
  • +2 more
  • Sucroferric Oxyhydroxide Chewable Tablet
  • Aurora, Colorado
    University of Colorado Anschutz Medical Campus
Aug 9, 2022

Chronic Kidney Diseases Trial in Canada, United States (Ferric Citrate, Placebo)

Not yet recruiting
  • Chronic Kidney Diseases
  • Ferric Citrate
  • Placebo
  • Los Angeles, California
  • +10 more
Feb 2, 2021

Dialysis Related Complication Trial in L'Hospitalet de Llobregat (mHealth App)

Recruiting
  • Dialysis Related Complication
  • mHealth App
  • L'Hospitalet de Llobregat, Barcelona, Spain
    Hospital Bellvitge
Aug 2, 2022

Hyperphosphatemia, Anemia, Iron Deficiency, Renal Insufficiency Trial in United States (Ferric Citrate 1 gram Oral Tablet,

Completed
  • Hyperphosphatemia
  • +2 more
  • Ferric Citrate 1 gram Oral Tablet
  • Standard of care phosphate-lowering therapy
  • Anchorage, Alaska
  • +12 more
Nov 3, 2022

Kidney Failure, Chronic, Hyperphosphatemia Trial in Worldwide (Liberal phosphate target, Intensive phosphate target)

Recruiting
  • Kidney Failure, Chronic
  • Hyperphosphatemia
  • Liberal phosphate target
  • Intensive phosphate target
  • Camperdown, New South Wales, Australia
  • +70 more
Dec 5, 2022

Mortality Trial in United States (Hemodialysis)

Recruiting
  • Mortality
  • Hemodialysis
  • Birmingham, Alabama
  • +67 more
Jan 19, 2023

Performance of Colonoscopy, Tolerance of Colonoscopy Trial in Mexico city (Abdominal binder (Revive 3-in-1 Postpartum Recovery

Recruiting
  • Performance of Colonoscopy
  • Tolerance of Colonoscopy
  • Abdominal binder (Revive 3-in-1 Postpartum Recovery Support Belt)
  • Loose abdominal binder (Revive 3-in-1 Postpartum Recovery Support Belt)
  • Mexico city, Mexico
    Antonio Marmolejo
Jan 28, 2023

Physical Inactivity, Phosphate Overload, Visceral Obesity Trial (Sodium Phosphate, Sodium Chloride)

Not yet recruiting
  • Physical Inactivity
  • +2 more
  • Sodium Phosphate
  • Sodium Chloride
  • (no location specified)
Aug 5, 2022

Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (drug, other, biological)

Active, not recruiting
  • Anemia
  • +2 more
  • Birmingham, Alabama
  • +795 more
Jan 28, 2023

Hypertension Trial in Dallas (High Phosphate Phase, Low Phosphate Phase)

Recruiting
  • Hypertension
  • High Phosphate Phase
  • Low Phosphate Phase
  • Dallas, Texas
  • +2 more
Oct 28, 2021

Hemodialysis Patients Trial in New Taipei City (low phosphorus meals, control meals)

Unknown status
  • Hemodialysis Patients
  • low phosphorus meals
  • control meals
  • New Taipei City, Taiwan
    Shuang Ho Hospital
Dec 3, 2020